Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Haemophilia. 2010 Jul;16 Suppl 6:1-2. doi: 10.1111/j.1365-2516.2010.02298.x.

Optimizing the treatment of haemophilia B: laboratory and clinical perspectives.

Author information

  • Mount Sinai School of Medicine, New York, NY 10029, USA. louis.aledort@mountsinai.org

Abstract

Hemophilia A and B are traditionally thought of as a single bleeding disorder, viewed as opposite sides of the same coin. Yet the differences between the 2 forms of congenital hemophilia extend far beyond the type of deficient clotting factor--factor VIII for hemophilia A and factor IX (FIX) for hemophilia B. This supplement focuses on the unique laboratory and clinical issues associated with FIX replacement therapy for children and adults with hemophilia B.

PMID:
20561350
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk